IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 216 filers reported holding IMMUNOGEN INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,850,077 | -44.3% | 116,577 | -33.8% | 1.17% | -41.7% |
| Q2 2023 | $3,321,875 | +242.5% | 176,040 | -30.3% | 2.01% | +202.6% |
| Q1 2023 | $969,800 | -29.8% | 252,552 | -9.4% | 0.66% | -30.3% |
| Q4 2022 | $1,381,990 | +21.3% | 278,627 | +16.9% | 0.95% | -18.1% |
| Q3 2022 | $1,139,000 | +6.7% | 238,302 | +0.5% | 1.16% | +66.4% |
| Q2 2022 | $1,067,000 | -1.1% | 237,202 | +4.7% | 0.70% | +37.0% |
| Q1 2022 | $1,079,000 | -29.6% | 226,602 | +9.7% | 0.51% | -23.6% |
| Q4 2021 | $1,533,000 | +42.5% | 206,652 | +8.9% | 0.67% | +31.2% |
| Q3 2021 | $1,076,000 | -17.1% | 189,702 | -3.7% | 0.51% | -15.1% |
| Q2 2021 | $1,298,000 | -16.6% | 197,002 | +1.7% | 0.60% | -23.0% |
| Q1 2021 | $1,557,000 | -0.4% | 193,755 | -20.7% | 0.78% | -8.2% |
| Q4 2020 | $1,564,000 | – | 244,421 | – | 0.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |